These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1848054)

  • 1. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M
    N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Turpie AG; Gent M; Côte R; Levine MN; Ginsberg JS; Powers PJ; Leclerc J; Geerts W; Jay R; Neemeh J
    Ann Intern Med; 1992 Sep; 117(5):353-7. PubMed ID: 1503326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
    Levine MN; Gent M; Hirsh J; Weitz J; Turpie AG; Powers P; Neemeh J; Willan A; Skingley P
    Arch Intern Med; 1996 Apr; 156(8):851-6. PubMed ID: 8774203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis.
    Turpie AG
    Am J Surg; 1991 Apr; 161(4):532-6. PubMed ID: 1852136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo.
    Leclerc JR; Geerts WH; Desjardins L; Jobin F; Laroche F; Delorme F; Haviernick S; Atkinson S; Bourgouin J
    Thromb Haemost; 1992 Apr; 67(4):417-23. PubMed ID: 1321509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
    Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
    Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.
    Geerts WH; Jay RM; Code KI; Chen E; Szalai JP; Saibil EA; Hamilton PA
    N Engl J Med; 1996 Sep; 335(10):701-7. PubMed ID: 8703169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
    Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
    J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.